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The aim of this study was to investigate the relationship between fall risk increasing drugs (FRIDS) and
the risk of falls in regard to fall-related chronic diseases. In total, 39 primary care physicians in Germany
participated in the EvaMed Pharmacovigilance Network. Antihypertensives, non-steroidal anti-inflammatory
drugs, hypnotics and sedatives, antidepressants and psycholeptics were labelled as FRIDS. A fall was defined
according to a diagnosis in the chapter Injury or poisoning (S00-T14 in International Statistical Classification of
Diseases 10th Revision (ICD-10)). Patients older than or equal to 65 years with at least two doctor’s visits were
included. FRIDS were prescribed for 1768 patients from a total of 5124 patients included in the analysis.
FRIDS and seven chronic diseases were statistically significant associated with a higher risk of experiencing
a fall. The risk was highest for patients with a diagnosis abnormalities of gait and mobility, vertigo,
visual -impairment and weight loss, and increased by 50-90% with arthritis, diseases of arteries, arterioles and
capillaries and heart failure. From patients (N = 425) with at least one diagnosis of fall, 219 patients were
prescribed FRIDS. In 100 (45.7%) of cases the diagnoses for fall were made before and in 105 (47.9%) of
cases at least a month after the prescription of FRIDS. 14 (6.4%) patients had a prescription of FRIDS and a
diagnosis of fall within one month. Perceptual disorders, low walking speed and pain are prominent predictors for
falls in the elderly. A prescription of FRIDS selects more vulnerable patients having a higher risk of falls. However,
experiencing a fall is mainly due to the disease followed by treatment. Thus, not prescribing FRIDS will avoid only
a small number of falls.
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Enabling healthy human aging is one of the most chal-
lenging tasks for health care systems around the world.
At present the percentages of older people in the po-
pulations of European countries are steadily increasing,
leading to heightened requirements for socio-medical
services and health care. In 2011 Germany counted for
a total of 2.5 million care-dependent elderly persons,
which was an increase of 10% compared to the year
2007 (Statistisches Bundesamt, Wiesbaden 2013). Apart
from logistical problems such as the process of admitting* Correspondence: kheckenbach@havelhoehe.de
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reproduction in any medium, provided the origelderly persons to a nursing home (Tabali et al. 2013), the
prescribing of medication to elderly patients becomes an
increasing medical, but also economical issue. The
medication of elderly patients is a risk assessment be-
tween wanted and adverse drug reactions. In particu-
lar the intake of multiple medications leads to a lower
medication adherence (Hubbard et al. 2013), failing
vision and impaired physical functioning in elderly
patients (Scheffer et al. 2013). According to Tinetti
(2003) the intake of four or more prescribed remedies
denotes an established risk factor for falls in older
people.
Today a wide range of evidence exists regarding the
association of polypharmacia and the risk of falls. Ac-
cording to a meta analysis by Woolcott et al. (2009), theis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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non-steroidal anti-inflammatory drugs and antihyper-
tensives drugs increase the risk of falls. The influence of
fall risk increasing drugs (FRIDS) on falls or fall-related
injuries of elderly persons has been examined in a var-
iety of studies including hip fractures (Guo et al. 1998),
or focused on therapeutic groups such as psychotropic
agents (Pierfitte et al. 2001; Thapa et al. 1995, 1998;
Ziere et al. 2008; Milos et al. 2014). Other studies have
criticized these results and state that fall-related injuries
could also be caused by morbidity (Bauer et al. 2012). In
addition extensive research was conducted into the field
of disabilities and fall-related chronic diseases (Dunn
et al. 1992; Gabbe et al. 2013; Haagsma et al. 2011; Pilotto
et al. 2012; Stenhagen et al. 2013).
Up to 2013 only two studies have investigated the effects
of FRIDs using data within Germany (Bauer et al. 2012;
Schwab et al. 2000). In a case control study, Schwab et al.
(2000) found the intake of benzodiazepines to be a prom-
inent risk-factor for falls and hip fractures in the elderly.
The second study of Bauer et al. (Bauer et al. 2012) used
administrative data from a German health insurance com-
pany to show that incidence of injuries strongly increases
with doses of antidepressants, anxiolytics, hypnotics, seda-
tives, and antiarrhythmics. While the first study mainly
concentrated on falls related to a specific class of drugs,
the second study chose a more general approach. Our
study is the first of its kind investigating FRIDS medica-
tion with regard to fall-related chronic diseases. The aim
of the current study was to investigate the relationship be-
tween FRIDS and the risk of falls with regard to fall-




In total, 39 primary care physicians in Germany parti-
cipated in a multicenter observational study from 2004
to 2010. All of the participants were members of the
EvaMed Pharmacovigilance Network, which aims to eval-
uate complementary remedies in usual care with regard to
prescribing patterns, efficacy, and safety (Jeschke et al.
2009a, b). During the study participating physicians con-
tinued to follow their routine documentation procedures,
recording all treatment relevant diagnoses and all pre-
scriptions for each consecutive patient using their existing
computerized patient documentation system. Data were
transferred to the EvaMed Documentation server includ-
ing an exact time stamp. Diagnoses were coded according
to the 10th revision of the International Classification
of Diseases (ICD-10). Prescribed drugs were docu-
mented using the German National Drug Code (German:
Pharmazentralnummer; PZN) and categorized by the ana-
tomical, therapeutic chemical (ATC) classification system.Missing ICD-10 and PZN codes were added by the study
center. Data were included in the analysis if patients were
at least 65 years old, or turned 65 during the study period,
and visited the physician at least twice during the study
period, since two time events were included in the analysis
which was based on a diagnosis of falls in relation to a
prescription of FRIDS.
Definitions: FRIDS, (Recurrent) falls and fall related
chronic diseases
According to a meta-analysis antihypertensives (C02),
non-steroidal anti-inflammatory drugs (NSAIDs) (M01A),
hypnotics and sedatives (N05C), antidepressants (N06A),
psycholeptics and psychoanaleptics combination (N06C)
were named as FRIDS (Woolcott et al. 2009). Diagnoses
coded by ICD-10 as injury or poisoning (S00 - T14) were
regarded as falls. Excluded were diagnoses relating to bites
from animals, injuries caused by knives or burns and se-
quelae of injuries (war). A fall was defined as recurrent
falls, if different ICD-10 codes were recorded or the same
ICD-10 code was recorded after three quarters of a year
(274 days), to avoid counting duplicated events with long
lasting recovery. A possible connection between the intake
of FRIDS and a diagnosis of fall was assumed if the diag-
nosis was made within one month after the prescription,
with the consideration that the patient would be pre-
scribed FRIDs for an acute disease.
Fall-related chronic diseases were categorized in ab-
normalities of gait and mobility (incl. Parkinson disease)
(ICD-10: R26, R27,G20-G26)) (Stenhagen et al. 2013)
arthritis (ICD-10: M05, M06, M13, M15- M19, M47,
M48) (Stenhagen et al. 2013; Tinetti and Kumar 2010;
Oliver et al. 2004; Deandrea et al. 2010), cerebrovascular
disease (ICD-10: I60-I69)) (Dunn et al. 1992), chronic is-
chaemic heart disease chronic ischaemic heart disease
(ICD-10: I25) I25) (Dunn et al. 1992; Tinetti and Kumar
2010; Oliver et al. 2004; Deandrea et al. 2010), dementia
dementia (ICD-10: F00-F05, F10, F20)) (Tinetti and
Kumar 2010; Oliver et al. 2004; Deandrea et al. 2010),
depression depression (ICD-10: F32, F33)) (Tinetti and
Kumar 2010; Oliver et al. 2004; Deandrea et al. 2010)
diabetes (ICD-10: E10- E14, O24.0-O24.4, R73)) (Tinetti
and Kumar 2010; Oliver et al. 2004; Deandrea et al. 2010),
diseases of arteries, arterioles and capillaries diseases of ar-
teries, arterioles and capillaries (ICD-10: I70-I79, I80-I89,
I95-I99)) (Dunn et al. 1992; Tinetti and Kumar 2010;
Oliver et al. 2004; Deandrea et al. 2010), hearing impair-
ment hearing impairment (ICD-10: H90, H91)) (Dunn
et al. 1992), heart failure (ICD-10: I50, I09, I11)) (Dunn
et al. 1992; Stenhagen et al. 2013; Tinetti and Kumar
2010; Oliver et al. 2004; Deandrea et al. 2010), hyper-
tension (ICD-10: I10) I10) (Dunn et al. 1992), interverte-
bral disc disorders, dorsalgia (ICD-10: M51, M53, M54)
(Tinetti and Kumar 2010; Oliver et al. 2004; Deandrea
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nant neoplasm (ICD-10: C00-C97) C00-C97) (Dunn et al.
1992) osteoporosis (ICD-10: M80) (Dunn et al. 1992),
sleep disorders (ICD-10: G47), vertigo (ICD-10: H81, H82,
R42) H81, H82, R42) (Stenhagen et al. 2013), visual im-
pairment visual impairment (ICD-10: H53-H54)) (Dunn
et al. 1992), weight loss weight loss (ICD-10: E41, E46,
E64, R63.4)) (Dunn et al. 1992), incontinence (ICD-10:
R32 or ATC code = V07AN) R32 or ATC code = V07AN)
(Tinetti and Kumar 2010; Oliver et al. 2004; Deandrea
et al. 2010) and disability in moving as a pand disability in
moving as a pand disability in moving as a prescription of
walking and mobility aids.
Statistics
Descriptive analysis was used to determine prescrip-
tion rates and the distribution of chronic diseases. De-
scriptive statistics are presented with 95% confidence
intervals (CI).
To identify independently associated risk factors with
a diagnosis of fall as the dependent variable, a blockwise
modeling strategy was conducted. In a first model, age
and sex were used as continuous variables. In a further
model, each fall-related chronic disease was tested as a
risk factor adjusted for age and sex. A second model
tested the association of falls with all fall-related chronic
diseases with a p value < 0.15 adjusted for age and sex
and an OR >1. In a third model, the association between
FRIDS and falls was tested, controlling for age, sex and
fall-related chronic diseases Adjusted odds ratios (AOR)
with 95% confidence intervals (CI) were calculated. The
significance level was set at α = 0.05.
Hosmer-Lemeshow goodness-of-fit test was used to
assess how well the chosen model fits the data. Statis-
tical analysis was performed with R: ‘A Language and
Environment for Statistical Computing (2012).
The present study was based on secondary data pro-
vided by physicians. As such, the recommendations for
good practice in secondary data analysis (e.g. anonymi-
zation of data on prescriptions and diagnoses) developed
by the German Working Group on the Collection and
Use of Secondary Data (Ihle et al. 2012) were applied in
full. As no experimental research or intervention on
patients was applied, no ethical approval was needed.
Nevertheless, the study was approved by the responsible
data security official.
Results
Data were provided by 26 from a total of 39 physicians
from the EvaMed network. 5,124 patients with a mean
age of 73 years (CI 72.7-73.2) were included in the final
analysis. Female patients were 1.6 years older than male
(73.5 years, CI 73.3-73.8 versus 71.9 years, CI 71.7-72.1).
On average patients were under medical attention by thephysician for two years. During the study period 9,031
FRIDS were prescribed to 1,768 (100%) patients. NSAIDs
were prescribed most frequently, making up 37.6% (n =
3,398) of prescriptions to 1,030 (58.3%) patients, followed
by prescriptions for hypnotics and sedatives (29.3%, n =
2646) to 465 (26.3%) patients and antidepressants (23.5%,
n = 2,120) to 555 (31.4%) patients. Antihypertensives were
only prescribed 867 times (9.6%) to 242 (13.7%) patients.
No prescription of combinations of psycholeptics and psy-
choanaleptics was documented. At least one diagnosis of
fall had 425 patients, more than half of them received a
prescription of FRIDS (n = 219) (Table 1).
In 14 of these cases (6.4%), a first diagnosis of fall oc-
curred within one month after the first prescription of
FRIDS. In 100 (45.7%) of cases the diagnoses for fall
were made before (at mean 231.8 (CI 144.2-319.4) days)
and in 105 (47.9%) of cases at least a month (at mean
768.6 (CI 625.5-911.7) days) after the prescription of
FRIDS.
From the 14 patients with a possible causative rela-
tionship between prescription of FRIDS and falls, pa-
tients were prescribed seven times NSAIDs, three times
hypnotics and sedatives and antidepressants, and one
prescription of antipsychotics (Table 2). The diagnoses
were fractures (9), contusions (5) and superficial injuries
(4). Body parts included head (1), upper limb (6), trunk
(5), lower limb (4) and twice parts were not specified.
Apart from two cases of fractures of the spine return-
ing to the physician two days after the prescription of
FRIDS, it is likely for all other cases that patients ini-
tially received the prescription and had fallen afterwards.
The injuries were typical for breaking a fall with hands af-
fecting wrist, hands and forearm and without breaking a
fall with hands, affecting the shoulder and the trunk
(DeGoede et al. 2003). Apart from three patients, patients
generally had between 3 to 11 diagnoses of fall-related
chronic diseases. Two patients had been falling recurrently
with three diagnoses of falls.
The diagnoses of falls (n = 515) were analysed accord-
ing to the type and location of the injury. The type of
the diagnoses were mainly fractures (36.3%) and superfi-
cial injuries (34.0%) (Table 3). Injuries occurred mainly
at the upper limb (21%) and the trunk (19%). The lower
limb (leg, knee, ankle foot) was stated in 11% followed
by hip and thigh (8%). Thirty seven percent of the injur-
ies had multiple locations or were not documented with
a specific body region.
We conducted three logistic regression models testing
the hypothesis that age and sex, chronic diseases and
FRIDS would be independent risk factor for falls. In the
first model, increasing age was a statistically significant
risk factor for falls. Although sex was not statistically
significant associated it remained a strong known con-
founder in the model. Whilst controlling for age and
Table 1 Description of patients 65 years and older
Falls No falls Totals
Mean (95% CI) Mean (95% CI) Mean (95% CI)
Age (years) 74.5(73.7-75.4) 72.8(72.6-73) 73.0(72.7-73.2)
n(%) n(%) N(%)
Gender
Male 136(7.5) 1,683(92.5) 1,819(35.5)
Female 289(8.7) 3,016(91.3) 3,305(64.5)
Outcome
Injuries and poisoninga 425(100) 4,699(91.7) 425(8.3)
Diagnosis
Recurrent injuries or poisoning >1 79(100) 5,042(98.5) 79(1.5)
Number of fall ascociated chronic diseases <=1 138(5.7) 2,275(94.3) 2,413(47.1)
Chronic diseases >=2 287(10.6) 2,424(89.4) 2,711(52.9)
Abnormalities of gait and mobility (incl. parkinson)b 24(19) 102(81) 126(2.5)
Dementiaf 36(15.3) 199(84.7) 235(4.6)
Depressiong 82(13.6) 522(86.4) 604(11.8)
Diabetesh 68(10.4) 589(89.6) 657(12.8)
Diseases of arteries, arterioles and capillariesi 129(13.2) 851(86.8) 980(19.1)
Hearing impaimentj 21(21.4) 77(78.6) 98(1.9)
Heart failurek 80(16.2) 413(83.8) 493(9.6)
Hypertensionl 186(9.6) 1,754(90.4) 1,940(37.9)
Intervertebral disc disorders, dorsalgiam 105(12.5) 735(87.5) 840(16.4)
Malignant neoplasmn 66(5.7) 1,088(94.3) 1,154(22.5)
Osteoporoseo 3(8.3) 33(91.7) 36(0.7)
Sleep disordersp 55(15) 311(85) 366(7.1)
Vertigoq 38(25.5) 111(74.5) 149(2.9)
Visual impairmentr 19(22.1) 67(77.9) 86(1.7)
Weight losss 7(24.1) 22(75.9) 29(0.6)
Incontinencet 60(15.2) 336(84.8) 396(7.7)
Disability in movingu 27(10.3) 234(89.7) 261(5.1)
Medication
Fall risk increasing drugs (FRIDS)v 219(12.4) 1,549(87.6) 1,768(34.5)
References and ICD10 Codes: a) Injuries and poisoning (S00-S99, T00- T14), b) abnormalities of gait and mobility (incl. Parkinson) (ICD-10: R26, R27,G20-G26)
(Stenhagen et al 2013), c) arthritis (ICD-10: M05, M06, M13, M15- M19, M47, M48) (Stenhagen et al. 2013; Tinetti and Kumar 2010; Oliver et al. 2004; Deandrea
et al. 2010), d) cerebrovascular disease (ICD-10: I60-I69) (Dunn et al. 1992), e) chronic ischaemic heart disease (ICD-10: I25) (Dunn et al. 1992; Tinetti and Kumar
2010; Oliver et al. 2004; Deandrea et al. 2010), f) dementia (ICD-10: F00-F05, F10, F20) (Tinetti and Kumar 2010; Oliver et al. 2004; Deandrea et al. 2010), g)
depression (ICD-10: F32, F33) (Tinetti and Kumar 2010; Oliver et al. 2004; Deandrea et al. 2010), h) diabetes (ICD-10: E10- E14, O24.0-O24.4, R73) (Tinetti and Kumar
2010; Oliver et al. 2004; Deandrea et al. 2010), i) diseases of arteries, arterioles and capillaries (ICD-10: I70-I79, I80-I89, I95-I99) (Dunn et al. 1992; Tinetti and Kumar
2010; Oliver et al. 2004; Deandrea et al. 2010), j) hearing impairment (ICD-10: H90, H91) (Dunn et al. 1992), k) heart failure (ICD-10: I50, I09, I11) (Dunn et al. 1992;
Stenhagen et al. 2013; Tinetti and Kumar 2010; Oliver et al. 2004; Deandrea et al. 2010), l) hypertension (ICD-10: I10) (Dunn et al. 1992), m) intervertebral disc
disorders, dorsalgia (ICD-10: M51, M53, M54) (Tinetti and Kumar 2010; Oliver et al. 2004; Deandrea et al. 2010; Anonymous 2001; Rubenstein 2006], n) malignant
neoplasm (ICD-10: C00-C97) (Dunn et al. 1992), o) osteoporosis (ICD-10: M80) (Dunn et al. 1992), p) sleep disorders (ICD-10: G47), q) vertigo (ICD-10: H81, H82, R42)
(Stenhagen et al. 2013), r) visual impairment (ICD-10: H53-H54) (Dunn et al. 1992), s) weight loss (ICD-10: E41, E46, E64, R63.4) (Dunn et al. 1992), t) incontinence
(ICD-10: R32 or ATC code = V07AN) (Tinetti and Kumar 2010; Oliver et al. 2004; Deandrea et al. 2010), u) disability in moving as a prescription of walking and
mobility aids, v) Fall risk increasing drugs (FRIDS) (ICD-10: C02, M01A, N05C, N06A, N06C) (Woolcott et al. 2009).
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with falls while malignant neoplasm was a protective fac-
tor in respect to falls (Table 4). The risk doubled at least
with the diagnoses of weight loss, vertigo, abnormalities
of gait and mobility. The risk increased more than 50%with a diagnoses of arthritis, heart failure, sleep disorder
or visual impairment. Patients with a diagnoses of de-
pression, intervertebral disc disorders and diseases of ar-
teries had an up to 50% increased risk. Adding FRIDS to
the model with independently associated diagnoses, the
Table 2 Single patients with a diagnosis fall within one month after prescription of FRIDS, falls sorted by ascending
distance to the prescription of FRIDS
Patient ATC code Name ICD-10 icd10 text Daysa Ageb
1 M01AE01 Ibuprofen T08.0 Fracture of spine, level unspecified 2 66
2 N05CC01 Chloral hydrate T08.0 Fracture of spine, level unspecified 2 89
3 M01AB05 Diclofenac- S42.3 Fracture of shaft of humerus 5 80
4 N05AH04 Quetiapine S00.0 Superficial injury of scalp (multi prescriptions 4.fall) 6 74
5 N06AP01 St. John’s wort S63.50 Sprain and strain of wrist 6 76
6 M01AH05 Etoricoxib S72.9 Fracture of femur, part unspecified 7 78
7 N06AB04 Citalopram S42.20 Fracture of upper end of humerus 8 89
8 M01AB05 Diclofenac- T08.0 Fracture of spine, level unspecified 11 62
9 M01AE17
Dexketoprofen S42.3 Fracture of shaft of humerus
13 91S52.50 Fracture of lower end of radius
S70.0 Contusion of hip
10 N05CF01 Zopiclone S72.00 Fracture of neck of femur 17 66
11 M01AB05 Diclofenac
S50.0 Contusion of elbow
28 93
S80.0 Contusion of knee
12 N05CD06 Lormetazepam S33.5 Sprain and strain of lumbar spine 28 65
13 M01AE01 Ibuprofen T14.1 Open wound of unspecified body region 29 62
14 N06AP01 St. John’s wort
T11.05 Superficial injury of upper limb, level unspecified
31 76
T14.00 Superficial injury of unspecified body region
aDays between prescription and fall.
bAge at diagnosis in years.
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remaining risk factors in the third model besides FRIDS
were diseases not treatable with FRIDS, but associated
with balance (vertigo, visual impairment, abnormalities
of gait and mobility), gait speed (weight loss and heart
diseases) and pain from a degenerative disease (arthritis).
Factors statistically significant associated with falls in the
model excluding FRIDS (depression, sleep disorders and
intervertebral disc disorders), were no longer associated,
when FRIDS was included in the model. In the second
model, the diagnoses depression, sleep disorders and in-
tervertebral disc disorders act as a representative for the
medication or further diagnoses leading to dizziness and
low walking speed. In the third model, FRIDS remained
as the important risk factor for falls.
Discussion
Firstly, our study contributes to the existing literature
by providing an analysis of FRIDS under consideration
of fall-related chronic diseases for the first time using
German data. Secondly, the empirical analysis is based
on routine data from physicians with 5,124 patients and
their data on prescriptions and diagnoses, including exact
dates. In regard to the constitution of the pharmacovigi-
lance network with active documentation of all adverse
events the EvaMed database exceeds all other secondary
data analysis e.g. German health insurance analysis. Thisenabled us to analyse the chronological sequence of pre-
scription of FRIDS and possible falls.
Although the routine data do not document the rea-
son for the fall, we assume most of the documented falls
are fall-related and not caused by any other external cau-
ses like car accidents. A prospective study with all resi-
dents (n = 679) aged 75 or 80 years from a city in Finland
was conducted to investigate types of injury and body re-
gions affected in injurious falls over a 10-year period. All
falls that required medical care were registered. From 718
accident-related injuries 88% were considered fall-related.
The most common injuries were fractures of the upper
limb and the hip. The frequencies of fractures and super-
ficial injuries are comparable with our distribution. In
contrast to the study from Finland, we have only a few in-
juries requiring first aid (superficial injuries of the head
and intracranial injuries) or treatment in a hospital (frac-
ture of the hip).
Our main results were that falls are potentially asso-
ciated with three factors:
Firstly, patients with a prescription of FRIDS are more
vulnerable and at a higher risk of falls, regardless of a
timely connection between drug use and fall. Although
the association between the use of FRIDS with falls in
elderly individuals has been demonstrated by Woolcott
et al. (2009), the connection between drug intake and
Table 3 Types of injury and body region affected
n (%) n
Dislocation, sprain and strain of joints and ligaments 70(13,6)
Head
Hip and thigh 2
Lower limb 16
Trunk 12











Open wound and injuries 79(15,5)
Head 5
















Intracranial injury Head 4
Sum 515(100) 515
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2003, Lamb et al. (2003) noticed the lack of evidence
with respect to the temporal association between
supposed risk factors and falls. Armstrong et al. (2005)
also raised the need for prospective studies to
characterise the temporal nature of the observed
associations.
As a second factor we found that patients with
perceptional disorders, visual and balance impairment
had the highest risk of experiencing a fall, which is in
accordance with a study about recurrent fallers and
their visit to an emergency department after afall (Askari et al. 2013). Besides known FRIDS
(analgetics, anti-Parkinson drugs, antipsychotics and
antidepressants, drugs for acid-related disorders),
nasal preparations and ophthalmologicals were
significantly associated with a visit in the emergency
department (Askari et al. 2013).
As a third factor we were able to confirm reduced
mobility (Stenhagen et al. 2013), low walking speed
(Quach et al. 2011; Muraki et al. 2013) and pain
(Muraki et al. 2013; Muraki et al. 2011) as prominent
predictors for falls in the elderly. The risk of falling for
patients with pain could be regarded as an adverse drug
reaction to NSAIDs, providing the chronology is not
being taken into account.
O’Neil et al. (2012) summarised studies and meta-
analyses on the treatment of pain with a focus on falls as
adverse drug reaction. A meta-analysis found that pa-
tients exposed to central acting analgesics (opioids) had
a 38% increased risk of fractures compared to non-treated
controls (Takkouche et al. 2007). Comparing peripheral
acting analgesics (NSAID) and opioids in older adults with
arthritis revealed a five-fold increased risk of fracture in
those using opioids. (Miller et al. 2011). Two studies de-
tected a dose dependence, where the risk of falls increased
with higher doses of opioids (Muraki et al. 2013; Saunders
et al. 2010). The risk of falling increased also if opi-
oids were used with non-opioid analgesics. One analysis
was conducted with regard to gait balance problems
(Buckeridge et al. 2010). Whether the falls originated
from the analgesics or from the underlying disease
remained unanswered. Most studies were unable to
control for pain severity which could have had an
important confounding effect (O’Neil et al. 2012).
Patients that received a prescription for opioids were
treated for moderate to severe pain, while NSAID’s
were generally used to treat only mild pain
(Schwabe and Paffrath 2014).
Only few studies investigated the effect of the with-
drawal of medication. Withdrawal significantly reduced
the expected rate of falls (incidence density), but not
the cumulative falls incidence (Campbell et al. 1999;
Zermansky et al. 2006). In more than 50% of patients
from a geriatric outpatient population (n = 139) a reduc-
tion of the risk of falling was achieved by the withdrawal
of cardiovascular drugs, antihypertensives, antiarrhyth-
mics, nitrates and other vasodilators, digoxin and
β-adrenoceptor blocker .
Further correlations between medication and falls were
found in other studies. Any type of change in the class
of psychotropic drugs increased the risk of a fall (Echt
et al. 2013). In addition, the risk of a fall increased
independent of the drug class in patients with diabe-
tes if they were prescribed four or more medications
Table 4 Regression models with falls as dependent variable
Model 1 Model 2 Model 3 Final Model
AOR (95% CI) Crude OR (95% CI) p value AOR (95% CI) p value AOR (95% CI) p value AOR (95% CI) p value
Age in years 1.024(1.012-1.036) <0.001 1.01.0(0.997-1.024) <=0.15 1.011.0(0.998-1.024) <=0.15 1.013(1.001-1.026) <0.05
Female gender 1.1(0.9-1.4) >0.15 1.0(0.8-1.3) >0.15 1.0(0.8-1.3) >0.15 1.0(0.8-1.3) 0.675
Abnormalities of gait and mobility (incl. parkinson) 2.6(1.6-4) <0.001 2.1(1.3-3.3) <0.05 2.0(1.2-3.2) <0.05 2.1(1.3-3.4) <0.05
Arthritis 2.0(1.6-2.5) <0.001 1.5(1.2-1.9) <0.001 1.4(1.1-1.8) <0.05 1.5(1.2-1.9) <0.001
Cerebovascular disease 1.8(1.3-2.5) <0.001 1.3(0.9-1.9) <=0.15 1.4(0.9-1.9) <0.1 - -
Chronic ischaemic heart disease 1.1(0.8-1.5) >0.15 - - - - - -
Dementia 1.8(1.2-2.6) <0.05 1.3(0.8-1.9) >0.15 - - - -
Depression 2.0(1.5-2.5) <0.001 1.4(1.1-1.9) <0.05 1.3(1.0-1.7) <0.1 - -
Diabetes 1.3(1.0-1.7) <0.1 1.1(0.8-1.4) >0.15 - - - -
Disability in moving 1.1(0.7-1.7) >0.15 - - - - - -
Diseases of arteries, arterioles and capillaries 1.9(1.6-2.4) <0.001 1.4(1.1-1.8) <0.05 1.4(1.1-1.8) <0.05 1.5(1.2-1.9) <0.001
Hearing impaiment 2.9(1.7-4.7) <0.001 1.6(0.9-2.8) <0.1 1.7(1.0-2.8) <0.1 - -
Heart failure 2.2(1.6-2.8) <0.001 1.6(1.2-2.1) <0.05 1.6(1.2-2.1) <0.05 1.7(1.3-2.3) <0.001
Hypertension 1.3(1.0-1.6) <0.05 1.1.0(0.9-1.4) >0.15 - - - -
Incontinence 1.9(1.3-2.5) <0.001 1.3(0.9-1.8) <=0.15 1.3(0.9-1.8) <=0.15 - -
Intervertebral disc disorders, dorsalgia 1.8(1.4-2.3) <0.001 1.3(1.0-1.7) <0.05 1.2(0.9-1.6) <=0.15 - -
Malignant neoplasm 0.6(0.5-0.8) <0.001 - - - - - -
Osteoporose 0.9(0.2-2.6) >0.15 - - - - - -
Sleep disorders 2.1(1.5-2.8) <0.001 1.5(1.0-2.0) <0.05 1.4(1.0-1.9) <0.1 - -
Vertigo 3.7(2.5-5.4) <0.001 2.5(1.6-3.8) <0.001 2.5(1.6-3.7) <0.001 2.9(1.9-4.2) <0.001
Visual impairment 3.4(1.9-5.5) <0.001 1.9(1.0-3.3) <0.05 1.9(1.0-3.3) <0.05 2.1(1.2-3.6) <0.05
Weight loss 3.6(1.4-8.2) <0.05 2.9(1.1-6.7) <0.05 2.8(1.1-6.6) <0.05 3.1(1.2-7.1) <0.05
Fall risk increasing drugs (FRIDS) <0.001 - - 1.5(1.2-1.9) <0.001 1.7(1.4-2.1) <0.001
Regression models with falls as dependent variable: Model 1 age and sex. Each fall-related chronic diseases, was tested as a risk factor adjusted for age and sex. Model 2 included all fall-related chronic diseases with a
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http://www.springerplus.com/content/3/1/483(Huang et al. 2010), confirming the results of Tinetti
(2003).
A reduction of falls in frail elderly could not be
achieved with a single intervention and it is questionable
whether the withdrawal of FRIDs medication would have
an effect. Even multifactorial interventions recommen-
ded by an international guideline (Anonymous 2001)
were not supported by the results of studies.
A Health technology assessment (HTA) for the German
situation addresses the effectiveness of single interventions
and complex programs for the prevention of falls and
fall-related injuries. The assessment included 184 out of
12,000 studies. A prior assessment of individuals at risk
of falling had no or little effect. Positive effects of exer-
cise interventions in relatively young and healthy se-
niors were observed, while the opposite was noted in
the fragile elderly. For this specific vulnerable popula-
tion modification of the housing environment showed
protective effects. A number of low quality studies and
inconsistent results led to the conclusion that the effect-
iveness of the following interventions is unclear: correc-
tion of vision disorders, modification of psychotropic
medication, vitamin D and nutritional supplementation,
psychological interventions, education of nursing per-
sonnel, multiple and multifactorial programs as well as
the application of hip protectors (Balzer et al. 2012).
Limitations:
The present study has important limitations which
should be taken into account when interpreting the
results.
Firstly, each diagnosis of poisoning and injury was
regarded as a fall. This might overestimate the number
of falls.
Secondly, although physician-prescribing data were
subjected to an internal review, coding inaccuracies
cannot be ruled out entirely.
Thirdly, data on additional medication use in
patients who visited several physicians
simultaneously were unavailable and might
underestimate the use of FRIDS.
Conclusions
In addition to the normal risk of falling, people included
in the elderly population lose the ability to prevent falls
and the protection reaction to minimize the conse-
quences of falls. Each patient at a higher risk should be
screened for their causal reasons and their individual
modifiable factors for fall prevention. Main issues are
pain reduction, stable walking and adequate medication
in regard to the quantity and the duration. Our data sug-
gest not that FRIDS medication are the source of falls
but are often applied in risk diseases for falls. For more
evidence regarding the temporal correlation of drug intakeand falls we suggest to analyse computerized prescrip-
tion databases to understand the temporal nature of
falls in the elderly. Furthermore, the evaluation of the
necessity of medication, especially psychotropic substan-
ces, should be examined for each individual at least yearly
(Bergert et al. 2013).
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